These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 2482572)

  • 21. The applicability of a keratin 7 monoclonal antibody in routinely Papanicolaou-stained cytologic specimens for the differential diagnosis of carcinomas.
    Baars JH; De Ruijter JL; Smedts F; Van Niekerk CC; Poels LG; Seldenrijk CA; Ramaekers FC
    Am J Clin Pathol; 1994 Mar; 101(3):257-61. PubMed ID: 7510926
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Value of the MOC-31 monoclonal antibody in differentiating epithelial pleural mesothelioma from lung adenocarcinoma.
    Ordóñez NG
    Hum Pathol; 1998 Feb; 29(2):166-9. PubMed ID: 9490276
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunohistochemistry in the distinction between malignant mesothelioma and pulmonary adenocarcinoma: a critical evaluation of new antibodies.
    Abutaily AS; Addis BJ; Roche WR
    J Clin Pathol; 2002 Sep; 55(9):662-8. PubMed ID: 12194995
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ME1. A monoclonal antibody that distinguishes epithelial-type malignant mesothelioma from pulmonary adenocarcinoma and extrapulmonary malignancies.
    O'Hara CJ; Corson JM; Pinkus GS; Stahel RA
    Am J Pathol; 1990 Feb; 136(2):421-8. PubMed ID: 2305835
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunohistochemical evaluation of pleural mesothelioma and pulmonary adenocarcinoma. A bi-institutional study of 47 cases.
    Otis CN; Carter D; Cole S; Battifora H
    Am J Surg Pathol; 1987 Jun; 11(6):445-56. PubMed ID: 2438954
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The use of vimentin antibodies in the diagnosis of malignant mesothelioma.
    Jasani B; Edwards RE; Thomas ND; Gibbs AR
    Virchows Arch A Pathol Anat Histopathol; 1985; 406(4):441-8. PubMed ID: 3925619
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The distinction of adenocarcinoma from malignant mesothelioma in cell blocks of effusions: the role of routine mucin histochemistry and immunohistochemical assessment of carcinoembryonic antigen, keratin proteins, epithelial membrane antigen, and milk fat globule-derived antigen.
    Cibas ES; Corson JM; Pinkus GS
    Hum Pathol; 1987 Jan; 18(1):67-74. PubMed ID: 2434407
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of cytokeratin 5/6 in epithelial neoplasms: an immunohistochemical study of 509 cases.
    Chu PG; Weiss LM
    Mod Pathol; 2002 Jan; 15(1):6-10. PubMed ID: 11796835
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Monoclonal antibody K1 reacts with epithelial mesothelioma but not with lung adenocarcinoma.
    Chang K; Pai LH; Pass H; Pogrebniak HW; Tsao MS; Pastan I; Willingham MC
    Am J Surg Pathol; 1992 Mar; 16(3):259-68. PubMed ID: 1599018
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Distinctive microvillous brush border staining with HBME-1 distinguishes pleural mesotheliomas from pulmonary adenocarcinomas.
    Dahlstrom JE; Maxwell LE; Brodie N; Zardawi IM; Jain S
    Pathology; 2001 Aug; 33(3):287-91. PubMed ID: 11523926
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vimentin, carcinoembryonic antigen and keratin in the diagnosis of mesothelioma, adenocarcinoma and reactive pleural lesions.
    al-Saffar N; Hasleton PS
    Eur Respir J; 1990 Oct; 3(9):997-1001. PubMed ID: 1705232
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunohistochemical evaluation of seven monoclonal antibodies for differentiation of pleural mesothelioma from lung adenocarcinoma.
    Wirth PR; Legier J; Wright GL
    Cancer; 1991 Feb; 67(3):655-62. PubMed ID: 1702354
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of calretinin, thrombomodulin, keratin 5, and mesothelin in lung carcinomas of different types: an immunohistochemical analysis of 596 tumors in comparison with epithelioid mesotheliomas of the pleura.
    Miettinen M; Sarlomo-Rikala M
    Am J Surg Pathol; 2003 Feb; 27(2):150-8. PubMed ID: 12548160
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Monoclonal antibodies against mesothelial membrane antigen discriminate between malignant mesothelioma and lung adenocarcinoma.
    Stahel RA; O'Hara CJ; Waibel R; Martin A
    Int J Cancer; 1988 Feb; 41(2):218-23. PubMed ID: 3276635
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Keratin in human lung tumors. Patterns of localization of different-molecular-weight keratin proteins.
    Said JW; Nash G; Banks-Schlegel S; Sassoon AF; Murakami S; Shintaku IP
    Am J Pathol; 1983 Oct; 113(1):27-32. PubMed ID: 6194690
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Calretinin, thrombomodulin, CEA, and CD15: a useful combination of immunohistochemical markers for differentiating pleural epithelial mesothelioma from peripheral pulmonary adenocarcinoma.
    Comin CE; Novelli L; Boddi V; Paglierani M; Dini S
    Hum Pathol; 2001 May; 32(5):529-36. PubMed ID: 11381372
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The diagnostic distinction between malignant mesothelioma of the pleura and adenocarcinoma of the lung as defined by a monoclonal antibody (B72.3).
    Szpak CA; Johnston WW; Roggli V; Kolbeck J; Lottich SC; Vollmer R; Thor A; Schlom J
    Am J Pathol; 1986 Feb; 122(2):252-60. PubMed ID: 2418688
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The immunohistochemical diagnosis of mesothelioma. Differentiation of mesothelioma and lung adenocarcinoma.
    Ordóñez NG
    Am J Surg Pathol; 1989 Apr; 13(4):276-91. PubMed ID: 2648877
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunoperoxidase localization of keratin in human neoplasms: a preliminary survey.
    Schlegel R; Banks-Schlegel S; McLeod JA; Pinkus GS
    Am J Pathol; 1980 Oct; 101(1):41-9. PubMed ID: 6160769
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Are keratin proteins a better tumor marker than epithelial membrane antigen? A comparative immunohistochemical study of various paraffin-embedded neoplasms using monoclonal and polyclonal antibodies.
    Pinkus GS; Etheridge CL; O'Connor EM
    Am J Clin Pathol; 1986 Mar; 85(3):269-77. PubMed ID: 2428237
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.